Skip to content
Pages
News
- Matica Biotechnology and VaxDome, Inc. Partner to Develop Antigen-Agnostic Antiviral-Vaccine Hybrids with Influenza as One of the Disease Models
- Matica Biotechnology Launches Integrated Korea IIT Platform Solution to Accelerate Global Advanced Therapy Development
- Matica Biotechnology and Cirsium Biosciences Announce Adoption of Matica Open Access Platform to Accelerate Flexible AAV Manufacturing
- Matica Biotechnology announces engagement by University Health Network (UHN) to supply cGMP Manufacturing of IL-10 Adenoviral Therapy for Lung Transplantation
- Matica Bio, a CDMO Leader in Oncolytic Virus Manufacturing, Partners with Calidi Biotherapeutics to Advance Calidi's Project Toward IND
- Matica Biotechnology Emerges as the Go-To CDMO for Cell & Gene Therapy
- Matica Bio Secures Commercial Manufacturing Deal with U.S. Biotech Company
- Matica Biotechnology and Cirsium Biosciences Announce AAV Manufacturing Collaboration
- Matica Biotechnology and Texas A&M's NCTM Form Strategic Partnership to Deliver End-to-End Support for Cell and Gene Therapy Innovators
- College Station CDMO partners with nonprofit to develop treatments for rare diseases
- Child's Cure Genetic Research collaborates with Matica Bio to Drive Innovation in Pediatric Rare Disease Therapies
- Treovir and Matica Bio Forms Strategic Partnership to Advance Innovative Therapies for Pediatric Brain Tumors
- Matica Biotechnology Appoints Life Sciences Leader Min Park, MBA to Chief Commercial Officer
- Transforming Viral Vector Analytics: Matica Bio’s Innovative Approach to Capsid Analysis
- Matica Biotechnology Establishes CDMO Partnership with KaliVir Immunotherapeutics
- Strategic Partnership Between Matica Bio and Mongoose Bio to Accelerate TCR-T Cell Therapy Development
- Matica Bio and CytoImmune Establish a Strategic Partnership for Cell Therapy Development and Manufacturing
- Matica Bio at BIO International 2024: Leading the Way in CGT Innovation and U.S. Manufacturing Strategy
- Matica Biotechnology: Filling the void
- Matica Bio Appoints Life Sciences Veteran Paul Kim as Chief Executive Officer
- Advanced Therapy Grapples with Standardized Techniques
- Matica Bio Welcomes Four Life Sciences Visionaries as Members of Advisory Board
- Innovations and Trends in Aseptic Manufacturing Processes
- Matica Bio Appoints Life Sciences Veterans Laura Parks, Heather N. Sugrue to Top Leadership Positions
- The Role Manufacturing Will Play in Advancing CGTs
- Matica Bio Launches MatiMax™ Cell Lines at BIO International Convention
- Cell and Gene Therapy Industry Comes Together for Matica Bio’s New Global Event
- Matica Bio Opens New Cell & Gene Therapy GMP Facility in Texas
- CHA Medical & Bio Group Announces Groundbreaking for Its New Cell Gene Biobank Facility
- Matica Bio Announces Joint Research Agreement with Sartorius for the Development of Advanced Viral Vector Manufacturing Technology
- Matica Biotechnology, Inc. Appoints Yun Jeong Song as new CEO
- As viral vector demand surges, CDMO Matica establishes a beachhead in Texas
- Matica Biotechnology, Inc. Announces Master Research Agreement with Texas A&M
- Matica Biotechnology, Inc. Announces Groundbreaking for New GMP Facility
- Matica Biotechnology, Inc. Announces Plans to Construct GMP Facility for Viral Vector Production
- CHA Biotech to Raise $62 mn to Bolster CDMO Business
Events
Leadership
;)